Please click here to view a write up on the 2013 Congress
VASCULAR 2013 CERTIFICATE OF ATTENDANCE - visit http://www.vascular2013.ca/en/postcongress.asp
Opening Plenary Speaker
Saturday October 19th, 2013
CCCN is please to announce Dr. Joan Tranmer RN, BScN (Queen's), MSc (Queen's), PhD (Toronto) as its opening plenary speaker.
Healthcare Work Environment & Cardiovascular Risk!
Healthcare work environment and cardiovascular risk - an exploration of work related factors (such as shift work, job stress, long hours etc.) that may be related to increased risk for cardiovascular disease and diabetes. The topic is relevant as current findings suggest that the prevalence and incidence of persons with indicators of CV risk and/or pre-diabetes in increasing in persons between the age of 45 - 65yrs.
The average age of nurses (and health workers) is around 47 years. As well, health care workers have the highest rate of lost time from work (Canadian stats)... perfect storm is brewing as the health care work force who cares for the unwell are not optimally well themselves! Dr. Tranmer will discuss the prevalence of the "problem", evidence linking work-related factors to CVR, and some of the findings from current studies.
Joan is an Associate Professor at Queen's University and is involed in both undergraduate and graduate teaching at the School of Nursing and graduate teaching within the Department of Community Health and Epidemiology. She contributes to the nursing undergraduate program in two ways: (1) teaching the maternal- child theoretical component of the family nursing course (N315) and (2) teaching aspects of the quantitative component of the research methods course (N324). Both these opportunities build upon her clinical and research expertise. Joan supervises graduate students in Nursing and Community Health and Epidemiology. Student's research foci are complementary to her areas of research expertise and focus, allowing for many opportunities to learn and teach from each other.
As a career scientist, she works with interdisciplinary teams in the conduct of research primarily focused on systematic examination and gender-based analyses of patient, caregiver, and system outcomes of care for persons living with chronic cardiovascular and cancer conditions; and on the development and testing of nurse led delivery systems to enhance quality of care. A secondary research focus is on the understanding of factors that contribute to quality work environments for healthcare workers and the development of policy and strategies to improve healthcare work environments, with a particular focus on female workers and cardiovascular health. Joan holds research grant funding from the Canadian Institutes of Health Research, Ontario Ministry of Health and Longterm Care, Canadian Breast Cancer Foundation, Oncology Nursing Foundation and other peer reviewed funding bodies.
Please click here for her full curriculum vitae.
[Back to Top]
Health Promotion and Advocacy Activity
Sunday October 20th, 2013
CCCN is please to announce Dr. Jacques Genest MD, FRCP(C) Cardiologist as its health promotion and advocacy speaker.
|ABC’s of Diabetes |
Diabetes mellitus, is a metabolic disease characterized by elevated blood sugar –either because the pancreas cannot (or can no longer) produce insulin, or because cells in the body fail to respond to insulin. The major long-term sequelae of diabetes are cardiovascular diseases. Indeed, diabetes is one of the strongest risk factors for cardiovascular diseases, especially myocardial infarctions and strokes. At least 6-85% of people with diabetes die from some form of heart disease or stroke. Diabetes increases atherosclerosis (narrowing of the blood vessels) dramatically – this is known as macro-vascular disease and leads to coronary artery disease, cerebrovascular disease and disease of the lower extremities. Diabetes also causes disease of the small arterioles (micro-vascular disease), leading to kidney failure and blindness; and sensory nerves, leading to neuropathies.
People with diabetes, particularly type 2 diabetes, often have associated conditions that contribute to their risk for developing cardiovascular disease, including obesity, physical inactivity, high blood pressure, abnormal cholesterol and triglyceride levels in blood and cigarette smoking.
In the past decade, the aims of treatment of diabetic subjects have shifted from a glucocentric approach to vascular protection through a multi-disciplinary approach. Diabetic subjects are now considered to be at high cardiovascular risk of they are 40 years of age or have had diabetes for more than 15 years duration or they have evidence of microvascular disease.
The current recommendation for treatment include lifestyle modifications: no smoking; a diet rich in fruits and vegetables, low in salt and saturated fats; a decrease in caloric intake to achieve a lower body weight; daily physical activity and stress management. In addition, reaching a level of hemoglobin A1c (HgA1c –an index of chronic control of blood sugar) to <7%; decreasing blood pressure to <130 mmHg and lower LDL-cholesterol to <2 mmol/L are agreed upon recommendations in Canada. This is best accomplished by a model of care that involves multiple stakeholders, reinforcement regarding compliance, monitoring and adherence to treatment –not an easy task. A current “hot topic” in the field of diabetes is the role of new anti-diabetic medications for the prevention of cardiovascular diseases
Biography: Jacques Genest obtained his MD at McGill University and did a residency in Internal Medicine at McGill then a cardiology fellowship at Tufts University in Boston. He did Post-doctoral studies in Boston in lipoprotein metabolism and molecular genetics at Tufts University. Since 2000, he is Professor of Medicine and holds the McGill/Novartis Chair in Medicine at McGill. From 2000-10, he was Head of Cardiology at McGill University. He is currently Scientific Director of the Center for Innovative Medicine at the McGill University Health center (MUHC).
His research focuses on the metabolic and genetic basis of premature coronary artery disease and the role of high density lipoproteins (HDL) in atherosclerosis. His research team has contributed to the identification of several genes involved in the metabolism of HDL. His research funding comes from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada. He has been involved in designing and running several large clinical trials (HOPE-2, homocysteine; the JUPITER trial) and is a member of the steering committees of currently on-going trials. He sits on several advisory boards for the pharmaceutical and biotechnology companies and is a reviewer for many scientific journals and granting agencies. He has published over 250 peer-reviewed manuscripts in journals such as Nature Genetics, Circulation, Circulation Research, New England Journal of Medicine, Journal of Biological Chemistry and The Lancet and has written 18 book chapters. For the past 16 years, he has participated in the elaboration of Canadian Cholesterol Guidelines.
[Back to Top]
Closing Plenary Session
Sunday October 20th, 2013
CCCN is please to announce Dr. Sylvie Cossette,inf., Ph.D., Université de Montréal as its closing plenary speaker.
|Nursing Intervention Research: Improving the recovery of Cardiac Patients!|
Nurses play a central role in improving the recovery of cardiac patients. This knowledge, often implicit, was transformed into evidence-based knowledge during the last ten years at the Montreal Heart Institute, Montreal. Based on clinical practice questions, our team developed nursing intervention studies to improve cardiac recovery. This presentation will describe the systematic development of nursing intervention research highlighting the contribution of clinicians, stakeholders, graduate students and researchers in all steps of the research program. The results of empirical research studies form the different cardiac contexts of acute coronary syndrome, chronic heart failure, and cardiac surgery will be described.
Biography: Dr. Sylvie Cossette, RN, PhD, is Full Professor at the Faculty of Nursing, University of Montreal and Researcher at the Montreal Heart Institute Research Center, Montreal, Québec, Canada. She is Co-Director of the Quebec Nursing Intervention Research Network.
[Back to Top]
Pulse. No Problem. What you Need to Know About Ventricular Assistive Device
Tuesday March 17, 2020
10:00 PDT, 11:00 MDT, 13:00 EDT, 14:00 ADT.